We can buy this stock at 0,61$, Sangamo Therapeutics Inc, with address at 7000 MARINA BOULEVARD, BRISBANE, California, 94005, United States, is a publicly traded company and its visible heads at the moment are Alexander D. Macrae (President, Chief Executive Officer & Director), Bettina M. Cockroft (Chief Medical Officer & Senior Vice President), Jason D. Fontenot (Chief Scientific Officer), Mark D. McClung (Chief Business Officer & Executive Vice President), Prathyusha Durabaibu (Senior VP, Chief Financial & Accounting Officer), R. Andrew Ramelmeier (Executive Vice President-Technical Operations). Focused on Biotechnology: Biological Products (No Diagnostic Substances) was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 0,59$ moving between 0,57$ and 0,62$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
